AXOVANT GENE THERAPIES LTD

CUSIP: G0750W203 Class: COM

PRIMECAP MANAGEMENT CO/CA/'s Holding History (CIK: 0000763212)

Note: Option positions (PUT/CALL) are excluded.

Q3 2020
Shares 53,225 Value ($000) $246 Avg Close — Range —
Q2 2020
Shares 55,125 Value ($000) $155 Avg Close — Range —
Q1 2020
Shares 73,825 Value ($000) $180 Avg Close — Range —
Q4 2019
Shares 120,425 Value ($000) $617 Avg Close — Range —
Q3 2019
Shares 123,287 Value ($000) $796 Avg Close — Range —
Q2 2019
Shares 124,287 Value ($000) $774 Avg Close — Range —